1. Backman, Joshua D, Li, Alexander H, Marcketta, Anthony, Abecasis, Gonçalo R, Ferreira, Manuel A R. 2021. Exome sequencing and analysis of 454,787 UK Biobank participants. In Nature, 599, 628-634. doi:10.1038/s41586-021-04103-z. https://pubmed.ncbi.nlm.nih.gov/34662886/
2. Yu, Xinnian, Xie, Linjun, Ge, Jianjuan, Zhong, Shanliang, Liu, Xiaolin. 2023. Integrating single-cell RNA-seq and spatial transcriptomics reveals MDK-NCL dependent immunosuppressive environment in endometrial carcinoma. In Frontiers in immunology, 14, 1145300. doi:10.3389/fimmu.2023.1145300. https://pubmed.ncbi.nlm.nih.gov/37081869/
3. Zhang, Yijian, Zuo, Chunman, Liu, Liguo, Chen, Luonan, Liu, Yingbin. 2021. Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer. In Journal of hepatology, 75, 1128-1141. doi:10.1016/j.jhep.2021.06.023. https://pubmed.ncbi.nlm.nih.gov/34171432/
4. Hashimoto, Masahiro, Kojima, Yasuhiro, Sakamoto, Takeharu, Shimamura, Teppei, Mimori, Koshi. 2024. Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis. In EBioMedicine, 103, 105102. doi:10.1016/j.ebiom.2024.105102. https://pubmed.ncbi.nlm.nih.gov/38614865/
5. Brauner, Asher, Fridman, Ofer, Gefen, Orit, Balaban, Nathalie Q. . Distinguishing between resistance, tolerance and persistence to antibiotic treatment. In Nature reviews. Microbiology, 14, 320-30. doi:10.1038/nrmicro.2016.34. https://pubmed.ncbi.nlm.nih.gov/27080241/
6. Zhao, Yu, Qin, Jie, Yu, Daohan, Jiang, Chuanlu, Cai, Jinquan. 2024. Polymer-locking fusogenic liposomes for glioblastoma-targeted siRNA delivery and CRISPR-Cas gene editing. In Nature nanotechnology, 19, 1869-1879. doi:10.1038/s41565-024-01769-0. https://pubmed.ncbi.nlm.nih.gov/39209994/
7. Du, Ashuai, Li, Shiqin, Zhou, Yuzheng, Peng, Jian, Xia, Zanxian. 2022. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. In Molecular cancer, 21, 109. doi:10.1186/s12943-022-01575-z. https://pubmed.ncbi.nlm.nih.gov/35524319/
8. Yan, Pengze, Jimenez, Ernesto Rojas, Li, Zheqi, Long, Henry W, Polyak, Kornelia. 2024. Midkine as a driver of age-related changes and increase in mammary tumorigenesis. In Cancer cell, 42, 1936-1954.e9. doi:10.1016/j.ccell.2024.09.002. https://pubmed.ncbi.nlm.nih.gov/39366375/
9. Schwitalla, Jan W, Le, Ngoc-Thao-Hien, Um, Soohyun, Baunach, Martin, Beemelmanns, Christine. 2023. Heterologous expression of the cryptic mdk gene cluster and structural revision of maduralactomycin A. In RSC advances, 13, 34136-34144. doi:10.1039/d3ra05931f. https://pubmed.ncbi.nlm.nih.gov/38019997/
10. Cerezo-Wallis, Daniela, Contreras-Alcalde, Marta, Troulé, Kevin, Olmeda, David, Soengas, María S. 2020. Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state. In Nature medicine, 26, 1865-1877. doi:10.1038/s41591-020-1073-3. https://pubmed.ncbi.nlm.nih.gov/33077955/